NCT00135460 - Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

November 30, 2007

Conditions

HIV-Associated Lipodystrophy Syndrome

Interventions

DRUG

nucleoside analogue sparing HAART regimen

Trial Locations (5)

Department of Infectious Diseases, Rigshospitalet, Copenhagen

Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre

Department of Infectious Diseases, Odense University Hospital, Odense

Department of Infectious Diseases, Aarhus University Hospital, Aarhus

Department of Infectious Diseases, Aalborg Hospital, Aalborg